Bilthoven, Netherlands

Sanne Weijzen


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sanne Weijzen

Introduction

Sanne Weijzen is a notable inventor based in Bilthoven, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of miRNA molecules for therapeutic applications. With a total of 4 patents, Weijzen's work is paving the way for advancements in medical treatments.

Latest Patents

Weijzen's latest patents focus on the diagnostic and therapeutic uses of miRNA molecules. One of his inventions addresses the treatment of diseases and conditions associated with neo-angiogenesis. This invention highlights the potential of miRNA molecules in diagnosing and treating various health issues. Another patent involves a miRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with Epithelial to Mesenchymal Transition (EMT). This innovative approach emphasizes the importance of miRNA in understanding and combating complex diseases.

Career Highlights

Sanne Weijzen is currently associated with Interna Technologies B.V., where he continues to explore the therapeutic potential of miRNA. His work is characterized by a commitment to advancing medical science through innovative research and development.

Collaborations

Weijzen collaborates with talented individuals in his field, including Roeland Quirinus Jozef Schaapveld and Willemijn Maria Gommans. These partnerships enhance the scope and impact of his research efforts.

Conclusion

Sanne Weijzen's contributions to the field of biotechnology through his innovative patents demonstrate his dedication to improving medical treatments. His work with miRNA molecules is a testament to the potential of scientific research in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…